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Abstract
ERCC1	(excision	repair	cross	complementing-group	1)	is	a	mammalian	endonuclease	
that	incises	the	damaged	strand	of	DNA	during	nucleotide	excision	repair	and	inter-
strand	cross-link	repair.	Ercc1−/Δ	mice,	carrying	one	null	and	one	hypomorphic	Ercc1 
allele,	have	been	widely	used	to	study	aging	due	to	accelerated	aging	phenotypes	
in numerous organs and their shortened lifespan. Ercc1−/Δ mice display combined 
features	of	human	progeroid	and	cancer-prone	syndromes.	Although	several	stud-
ies report cellular senescence and apoptosis associated with the premature aging of 
Ercc1−/Δ	mice,	the	link	between	these	two	processes	and	their	physiological	relevance	
in the phenotypes of Ercc1−/Δ	mice	are	incompletely	understood.	Here,	we	show	that	
ERCC1	depletion,	both	in	cultured	human	fibroblasts	and	the	skin	of	Ercc1−/Δ	mice,	
initially	induces	cellular	senescence	and,	importantly,	increased	expression	of	several	
SASP	(senescence-associated	secretory	phenotype)	factors.	Cellular	senescence	in-
duced	by	ERCC1	deficiency	was	dependent	on	activity	of	the	p53	tumor-suppressor	
protein.	 In	 turn,	 TNFα	 secreted	 by	 senescent	 cells	 induced	 apoptosis,	 not	 only	 in	
neighboring	ERCC1-deficient	nonsenescent	cells,	but	also	cell	autonomously	in	the	
senescent	cells	themselves.	In	addition,	expression	of	the	stem	cell	markers	p63	and	
Lgr6	was	significantly	decreased	in	Ercc1−/Δ	mouse	skin,	where	the	apoptotic	cells	are	
localized,	compared	to	age-matched	wild-type	skin,	possibly	due	to	the	apoptosis	of	
stem	cells.	These	data	suggest	that	ERCC1-depleted	cells	become	susceptible	to	ap-
optosis	via	TNFα	secreted	from	neighboring	senescent	cells.	We	speculate	that	parts	
of	the	premature	aging	phenotypes	and	shortened	health-	or	lifespan	may	be	due	to	
stem cell depletion through apoptosis promoted by senescent cells.
K E Y W O R D S
aging,	cell	death,	DNA	damage	repair,	senescence-associated	secretory	phenotype,	tumor	
necrosis factor α
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1  | INTRODUC TION
The	accumulation	of	DNA	damage	is	thought	to	be	a	major	driver	of	
age-related	degeneration	and	pathologies	and	is	considered	one	of	
the	hallmarks	of	 aging	 (Hasty,	Campisi,	Hoeijmakers,	 van	Steeg,	&	
Vijg,	2003).	The	major	defenses	against	the	genotoxic	and	cytotoxic	
consequences	of	DNA	damage	are	two	cell	fates:	cellular	senescence	
and apoptosis. To prevent the propagation of damaged or dysfunc-
tional	 cells,	 senescence	 arrests	 proliferation,	 essentially	 irrevers-
ibly,	but	senescent	cells	remain	viable	and	metabolically	active.	By	
contrast,	apoptosis	 is	a	 form	of	programmed	cell	death	and	there-
fore effectively eliminates damaged or dysfunctional cells. Despite 
being	distinct	cell	fates	with	different	outcomes,	both	can	be	ben-
eficial	 or	 deleterious,	 depending	 on	 the	 physiological	 context	 and	
age	(Campisi,	2013;	Childs,	Baker,	Kirkland,	Campisi,	&	van	Deursen,	
2014).	A	major	benefit	of	both	senescence	and	apoptosis	is	the	abil-
ity	to	suppress	the	development	of	cancer.	However,	both	cell	fates	
can also eventually compromise the ability of tissues to regenerate 
and/or function optimally.
Senescent	cells	accumulate	during	aging	and	at	sites	of	many	
age-related	pathologies	(Campisi,	2013;	Coppe,	Desprez,	Krtolica,	
&	Campisi,	2010).	The	persistent	presence	of	senescent	cells	can	
foster	 chronic	 inflammation,	 modify	 tissue	 microenvironments,	
and alter the functions of neighboring cells—all owing to the se-
cretion	 of	 numerous	 factors,	 including	 pro-inflammatory	 cyto-
kines,	 chemokines,	 growth	 factors,	 and	 proteases,	 termed	 the	
senescence-associated	 secretory	 phenotype	 (SASP)	 (Campisi,	
2013;	 Coppe	 et	 al.,	 2010,	 2008;	 Davalos	 et	 al.,	 2013;	 Kuilman,	
Michaloglou,	 Mooi,	 &	 Peeper,	 2010).	 Using	 transgenic	 mice	 in	
which	senescent	cells	can	be	selectively	eliminated,	both	lifelong	
and	late-life	clearance	were	shown	to	extend	median	lifespan	and	
attenuate	 several	 deleterious	 age-associated	 phenotypes;	 these	
benefits were apparent in both progeric and naturally aged mice 
(Baker	et	al.,	2011).	Thus,	cellular	senescence	has	emerged	as	an	
important causative driver of many aging phenotypes and pa-
thologies.	Likewise,	many	aging	phenotypes	and	pathologies	can	
arise owing to deficits in the control of apoptosis. Resistance to 
apoptosis	due	to	acquired	mutations	can	promote	cancer,	whereas	
overactivation	of	apoptosis	can	cause	tissue	atrophy	(Childs	et	al.,	
2014).
Cellular	senescence	and	apoptosis	share	certain	characteristics,	
including the ability to suppress tumorigenesis and potential to con-
tribute	to	aging	and	age-associated	diseases.	They	also	share	certain	
regulatory	axes,	such	as	control	by	the	p53-p21	and	PTEN-PI3K-Akt	
pathways	 (Childs	 et	 al.,	 2014).	Depending	on	 the	degree	of	 stress	
and	type	of	DNA	damage,	as	well	as	the	cell	type,	state,	and	history,	
cells	 may	 undergo	 either	 senescence	 or	 apoptosis.	 Interestingly,	
senescent	 cells	 are	 generally	 resistant	 to	 apoptosis	 (Childs	 et	 al.,	
2014;	Yosef	et	al.,	2016).	Nonetheless,	 senescent	endothelial	 cells	
can	 become	 susceptible	 to	 apoptosis	 upon	 reduced	 BCL-2	 or	 in-
creased	BAX	expression	 (Zhang,	Patel,	&	Block,	2002)	or	 reduced	
nitric	 oxide	 synthase	 (eNOS)	 (Li,	 Guo,	Dressman,	 Asmis,	 &	 Smart,	
2005;	Matsushita	 et	 al.,	 2001).	 The	molecular	mechanisms	 linking	
senescence	and	apoptosis,	especially	driven	by	DNA	damage,	have	
not	been	extensively	explored.
ERCC1	(excision	repair	cross	complementing-group	1)	is	a	DNA	
repair	protein	 that	 forms	a	heterodimer	with	XPF	 (xeroderma	pig-
mentosum	group	F-complementing	protein,	also	known	as	ERCC4)	
and	 functions	 as	 a	 5′-3′	 structure-specific	 endonuclease.	 It	 par-
ticipates	 in	 a	 number	of	DNA	 repair	 pathways	 in	mammalian	 cells	
(Dolle	et	al.,	2011;	Weeda	et	al.,	1997).	The	heterodimer	is	required	
for	incising	the	damaged	strand	of	DNA	during	nucleotide	excision	
repair	 (NER)	 and	 the	mechanistically	 related	 transcription-coupled	
repair	(TCR),	and	for	resolving	DNA	interstrand	cross-links	by	inter-
strand	cross-link	repair.	 In	addition,	 the	ERCC1/XPF	endonuclease	
is	important	for	single-strand	annealing	of	persistent	double	strand	
breaks	(Marteijn,	Lans,	Vermeulen,	&	Hoeijmakers,	2014).
Because	ERCC1/XPF	participates	 in	multiple	DNA	repair	path-
ways,	ERCC1/XPF	mutations	in	humans	are	associated	with	several	
distinct syndromes. These syndromes include Cockayne and cere-
bro-oculo-facial-skeletal	(COFS)	syndromes	characterized	by	severe	
progressive developmental deficiencies and neurological abnormali-
ties,	as	well	as	many	other	aging	phenotypes	and	an	extremely	short	
lifespan	 (Gregg,	 Robinson,	 &	 Niedernhofer,	 2011;	 Jaspers	 et	 al.,	
2007;	Niedernhofer	et	al.,	2006).	They	also	include	the	cancer-prone	
disorders	 xeroderma	pigmentosum,	Fanconi	 anemia,	 and	XFE	 syn-
drome	(Marteijn	et	al.,	2014).	An	important	tool	for	studying	these	
diverse syndromes is Ercc1−/Δ mice. These mice lack one functional 
Ercc1	allele	and	are	hemizygous	for	a	single	truncated	allele	encod-
ing a hypomorphic Ercc1 variant that lacks the last seven amino 
acids	 (Dolle	 et	 al.,	 2011;	Weeda	 et	 al.,	 1997).	 The	 lifespan	 of	 this	
mouse	is	significantly	truncated	(4–6	months)	and	the	animals	show	
numerous	premature	 aging	phenotypes,	 including	decreased	body	
weight,	prominent	global	neurodegeneration,	and	bone	marrow	fail-
ure	and	atrophy;	they	also	show	age-associated	pathology	in	major	
organs,	such	as	the	liver,	kidney,	skeletal	muscles,	and	vasculature,	
although in their short lifespan they do not develop overt neoplastic 
lesions	(Vermeij,	Hoeijmakers,	&	Pothof,	2016).	Several	groups	have	
described the presence of senescent cells in Ercc1−/Δ mice and sug-
gested a role for these cells in accelerating aging phenotypes and 
pathologies	when	there	is	a	defect	in	DNA	damage	repair	(Robinson	
et	al.,	2018;	Tilstra	et	al.,	2012;	Weeda	et	al.,	1997).	Concomitantly,	
apoptosis and its link to tissue atrophy and pathologies in the 
Ercc1−/Δ mice have been observed by other groups (Niedernhofer et 
al.,	2006;	Takayama	et	al.,	2014).	It	is	unclear	whether	and	how	these	
two	distinct	cell	fates	are	linked	in	this	DNA	damage-driven,	prema-
ture aging mouse model.
Here,	we	show	that	DNA	damage	driven	by	deficient	ERCC1	ex-
pression or activity promotes cellular senescence in human cells in 
culture and mouse skin in vivo.	Senescence	induced	by	ERCC1	down-
regulation	depended	on	p53	expression,	which	earlier	work	showed	
restrains	the	SASP	(Coppe	et	al.,	2008;	Rodier	et	al.,	2009).	We	also	
found	that	ERCC1-deficient	cells	undergo	apoptosis,	driven	primarily	
by	the	SASP	factor	TNFα.	TNFα	induced	apoptosis	via	extrinsic	apop-
totic	signaling	pathways,	and	TNFα	secretion	from	ERCC1-depleted	
senescent cells promoted apoptosis in neighboring nonsenescent 
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cells	 as	 well	 as	 senescent	 cells	 themselves.	We	 confirmed	 an	 in-
crease in apoptotic cells in the skin of Ercc1−/Δ	mice	 during	 aging,	
which	was	not	detected	in	skin	samples	from	age-matched	wild-type	
littermates.	We	also	 found	substantial	depletion	of	epithelial	 stem	
cells,	possibly	due	to	apoptosis,	in	older	Ercc1−/Δ	mouse	skin.	Finally,	
we	 determined	 that	 the	 SASP	 factor	 TNFα accelerated apoptosis 
in	ERCC1-depleted	cells,	which	likely	contributes	to	the	premature	
aging phenotypes and tissue dysfunction in Ercc1−/Δ mice.
2  | RESULTS
2.1 | ERCC1 deficiency promotes cellular 
senescence in skin
To	examine	the	accumulation	of	cellular	senescence	in	progressively	
aged Ercc1−/Δ mice in vivo,	we	compared	skin	tissues	of	Ercc1−/Δ ani-
mals	with	age-matched	littermates	and	older	wild-type	(wt)	control	
mice.	SA-β-gal	staining	showed	that	the	presence	of	senescent	cells	
in Ercc1−/Δ	 skin	 increased	progressively	 from	4	to	18	weeks	of	age	
and was always substantially higher than in skin from similarly aged 
(4–18	weeks)	control	wt	mice	(Figure	1a).	Interestingly,	skin	samples	
from	more	substantially	aged	(104	weeks	old)	wt	mice	showed	a	level	
of	senescent	cells	comparable	to	the	level	observed	in	18-week-old	
Ercc1−/Δ	mice.	Histological	 examination	 of	 the	 skin	 from	 18-week-
old skin of Ercc1−/Δ mutants showed typical signs of aging such as 
hyperplasia	of	the	epidermis	and	atrophy	of	the	dermis	(Figure	1a),	
possibly due to loss and degeneration of the elastic fiber network.
Senescent	 cells	 undergo	 nuclear	 reorganization,	 accompanied	
by	 a	 reduction	 in	 lamin	 B1	 (LMNB1)	 mRNA	 and	 protein	 (Freund,	
Laberge,	Demaria,	&	Campisi,	2012).	 Immunofluorescence	staining	
of	18-week-old	Ercc1−/Δ mouse skin showed a marked loss of nuclear 
LMNB1	 in	comparison	to	age-matched	wt	skin,	where	LMNB1	ex-
pression	was	clearly	detectable	(Figure	1b	and	Figure	S1A).	Similar	
to	the	skin	of	18-week-old	Ercc1−/Δ	mice,	the	skin	of	104-week-old	
wt	mice	displayed	a	loss	of	nuclear	LMNB1	protein.	Staining	for	the	
proliferation	marker	Ki67	showed	a	significant	reduction	in	the	skin	
of	18-week-old	Ercc1−/Δ	mice	compared	to	age-matched	wt	skin,	but	
similar	to	aged	wt	skin	(Figure	1c).
To determine whether there is a direct role for ERCC1 defi-
ciency	in	inducing	senescence,	we	used	lentiviruses	and	two	primary	
human	fibroblast	strains,	HCA2	and	 IMR-90,	 to	express	 two	 inde-
pendent	short	hairpin	RNAs	(shRNAs)	against	ERCC1	(shERCC1	#1	
and	#2).	Concomitant	with	 a	 decrease	 in	 ERCC1	protein	 levels	 by	
both	shRNAs,	there	was	a	significant	increase	in	the	number	of	SA-
β-gal-positive	cells	and	a	decline	in	the	number	of	proliferating	(EdU	
positive)	cells	7	days	after	infection	(Figure	2a–c).	In	addition,	there	
was	an	increase	in	mRNA	encoding	the	senescence	marker	p21,	but	
not	p16INK4a,	7	days	after	 infection	 (Figure	2d,	 left	panel;	Figure	
S1B,	left	panel).	However,	p16INK4a	mRNA	increased	at	later	time	
points,	that	is,	14	and	21	days	after	infection	(Figure	S1C).	Further,	
the	expression	(mRNA	level)	of	SASP	components,	such	as	cytokines	
(IL1α,	 IL6,	 TNFα)	 and	matrix	metalloproteinase	 (MMP3),	 increased	
significantly	 upon	ERCC1	depletion	 (Figure	 2d,	 right	 panel;	 Figure	
S1B,	 right	 panel).	 Immunofluorescence	 staining	 confirmed	 that	
ERCC1	depletion	resulted	in	a	loss	of	LMNB1	expression	(Figure	2e	
and	Figure	S1D),	loss	of	nuclear	HMGB1	(Figure	2f	and	Figure	S1E),	
and an increase in γH2AX	foci	(Figure	2g	and	Figure	S1F),	all	of	which	
can	also	serve	as	senescence	markers	(Davalos	et	al.,	2013;	Rodier	
et	 al.,	 2009).	 ERCC1	 depletion	 using	 siRNA	 further	 validated	 the	
increased	 number	 of	 SA-β-gal-positive	 cells,	 as	well	 as	 changes	 in	
expression	of	the	senescence	markers	measured	after	shRNA	deple-
tion	(Figure	2h-I).
2.2 | Cellular senescence induced by ERCC1 
deficiency is p53-dependent
To determine whether cellular senescence induced by ERCC1 de-
ficiency	 is	 p53-dependent,	 we	 used	 lentivirus-mediated	 shRNA	
depletion of p53 in fibroblasts in which ERCC1 was subsequently 
depleted.	The	increased	number	of	SA-β-gal-positive	cells	normally	
caused by ERCC1 depletion was substantially attenuated when p53 
was	depleted	as	a	first	step	 (Figure	3a).	Likewise,	the	downregula-
tion	of	p53	in	ERCC1-depleted	cells	dampened	the	increased	mRNA	
levels	of	p21,	a	downstream	target	of	p53,	without	affecting	ERCC1 
mRNA	 levels	 (Figure	 3b).	 However,	 the	 expression	 of	 SASP	 com-
ponents	 (IL1α,	 IL6,	and	TNFα	mRNAs)	was	enhanced	upon	double	
knockdown of p53/ERCC1 compared to a single knockdown of 
ERCC1	 (Figure	 3c),	 consistent	with	 the	 negative	 regulation	 of	 the	
SASP	by	p53,	as	reported	(Coppe	et	al.,	2008;	Rodier	et	al.,	2009).	
These results indicate that the senescence induced by ERCC1 defi-
ciency	is	p53-dependent	and	confirm	that	p53	restrains	SASP	factor	
expression.
2.3 | TNFα secreted by senescent cells 
promotes apoptosis
Our	findings	suggested	that	senescent	cells	might	play	a	causal	role	
in	the	age-related	phenotypes	of	Ercc1−/Δ mice. To test this possibil-
ity,	we	bred	Ercc1−/Δ	mice	with	p16-3MR	mice	and	senescent	cells	
were eliminated by treatment with ganciclovir. Eliminating senes-
cent	cells	neither	rescued	obvious	aging	phenotypes	nor	extended	
lifespan	 (Figure	 S2A),	 suggesting	 that	 other	mechanisms	drive	 the	
phenotypes	resulting	from	Ercc1	deficiency.	Indeed,	we	found	that	
ERCC1 deficiency in human fibroblasts not only induced cellular 
senescence,	 but	 also	 apoptosis.	 Immunofluorescence	 staining	 for	
cleaved	caspase	3	and	TUNEL	assays	 indicated	that	apoptosis	was	
significantly	increased	in	ERCC1-deficient	fibroblasts	(Figure	4a	and	
Figure	S2B,C).	Senescent	cells	are	reported	to	be	resistant	to	apop-
tosis	due	to	increased	expression	of	anti-apoptotic	proteins	such	as	
Bcl-2	(Childs	et	al.,	2014;	Yosef	et	al.,	2016).	However,	upon	ERCC1	
depletion,	 these	 two	distinct	 cellular	processes	appeared	 to	 coex-
ist.	To	understand	how	these	two	processes	were	related,	we	per-
formed	SA-β-gal	staining	followed	by	immunofluorescence	staining	
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for	 cleaved	 caspase	 3	 (Figure	 4b).	 About	 10%	 of	 the	 cells	 co-ex-
pressed	SA-β-gal	and	cleaved	caspase	3,	suggesting	that	senescence	
and	 apoptosis	 were	 concomitant	 in	 a	 fraction	 of	 ERCC1-deficient	
fibroblasts.	However,	20%–25%	of	ERCC1-deficient	fibroblasts	that	
were	not	SA-β-gal	positive	also	underwent	apoptosis.	These	findings	
raise the possibility that a paracrine factor produced by senescent 
ERCC1-deficient	fibroblasts	might	act	on	nonsenescent	neighboring	
cells.
TNFα	is	a	SASP	factor	and	known	regulator	of	apoptosis	(Jiang,	
Woronicz,	Liu,	&	Goeddel,	1999).	TNFα levels were shown to be sig-
nificantly	higher	in	sera	and	various	tissues,	including	fat	and	endo-
thelium,	 in	Ercc1−/Δ	mice	compared	to	age-matched	wt	mice	 (Chen	
et	al.,	2013;	Karakasilioti	et	al.,	2013;	Roh	et	al.,	2013).	Consistent	
with	mRNA	levels	(Figure	2d,	right	panel),	TNFα	secretion	by	ERCC1-
deficient fibroblasts was significantly higher than control fibroblasts 
(Figure	4c).	TNFα	was	shown	to	 impede	the	repair	of	certain	DNA	
F I G U R E  1  Accumulation	of	senescent	cells	in	the	skin	of	Ercc1−/Δ	mice.	(a)	Ercc1−/Δ	and	wild-type	(wt)	mouse	skin	at	the	indicated	
ages	were	stained	for	senescence-associated	β-galactosidase	(SA-β-gal,	blue)	activity	and	counterstained	with	nuclear	fast	red	(red).	
Representative	images	(left	panel)	and	quantification	(right	panel)	are	shown.	N = 2–4 animals per condition. Each dot in the graph 
corresponds to skin from a different animal. Data are mean ± SEM,	two-tailed	Welch's	adjusted	t-test.	(b,	c)	Representative	images	of	
immunofluorescence	staining	for	lamin	B1	(LMNB1)	(b)	and	Ki67	(c)	performed	on	Ercc1−/Δ and wt skin tissue from mice of the indicated 
genotype	and	age	(w	=	weeks).	DAPI	was	used	for	counterstaining.	Representative	images	are	shown,	and	n = 3 tissues were evaluated per 
condition. p-value:	*p	<	.05,	**p	<	.01,	***p < .001
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F I G U R E  2   Increased	cellular	senescence	in	ERCC1-deficient	human	fibroblasts.	(a)	Human	HCA2	skin	fibroblasts	infected	with	
lentiviruses	expressing	a	scrambled	shRNA	control	(scr)	or	expressing	an	shRNA	against	ERCC1	(shERCC1	#1	and	shERCC1	#2)	were	
analyzed	by	western	blotting	for	ERCC1	protein	levels	7	days	after	infection	(β-actin	was	used	for	normalization).	N	corresponds	to	
noninfected	cells.	(b)	SA-β-gal	staining	was	performed	on	the	three	populations	of	human	fibroblasts	described	in	A	(left	panel)	and	
quantification	of	the	percent	SA-β-gal-positive	cells	is	shown	(right	panel).	A	representative	experiment	from	three	independent	experiments	
is	shown,	n	=	3,	mean	±	SEM,	two-tailed	Welch's	adjusted	t-test.	(c)	EdU	staining	was	performed	on	the	three	populations,	and	quantification	
of	the	percent	EdU-positive	cells	is	shown.	A	representative	experiment	from	three	independent	experiments	is	shown,	n	=	5,	mean	±	SEM,	
two-tailed	Welch's	adjusted	t-test.	(d)	RNA	was	extracted	from	scrambled	control,	shERCC1	#1	and	#2	cell	populations,	and	analyzed	by	
qPCR	for	mRNA	levels	of	ERCC1	and	several	senescence	markers	(p21	and	p16	(left	panel);	IL1α,	IL6,	MMP3	and	TNFα	(right	panel)).	β-actin	
was	used	for	normalization.	n	=	3,	two-tailed	Welch's	adjusted	t-test.	(e–g)	Intensities	of	nuclear	LMNB1	(e)	and	nuclear	HMGB1	(f),	and	
percent cells with at least two γH2AX	foci	(g),	were	determined	in	the	three	cell	populations	by	immunofluorescence.	A	representative	
experiment	from	2	independent	experiments	is	shown,	n = 5 (n	=	4	only	for	scrambled	in	(f)),	mean	±	SEM,	two-tailed	Welch's	adjusted	t-
test.	(h)	SA-β-gal	staining	was	performed	on	human	fibroblasts	transfected	with	either	a	scrambled	siRNA	control	or	siRNA	against	ERCC1	
(siERCC1);	the	percent	SA-β-gal-positive	cells	is	shown.	n	=	3,	mean	±	SEM,	two-tailed	Welch's	adjusted	t-test.	(i)	RNA	was	extracted	from	
scrambled	control	and	siERCC1	cell	populations,	and	analyzed	by	qPCR	for	mRNA	levels	of	ERCC1,	and	various	senescence	and	SASP	
markers. β-actin	was	used	for	normalization.	n	=	2,	two-tailed	Welch's	adjusted	t-test.	p-value:	*p	<	.05,	**p	<	.01,	***p < .001
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lesions,	such	as	cyclobutane	pyrimidine	dimers,	and	increase	apop-
tosis	 in	 NER-incompetent	 cells	 via	 replication	 stress	 (Faurschou,	
Gniadecki,	 Calay,	 &	Wulf,	 2008).	We	 therefore	 hypothesized	 that	
ERCC1-deficient	 cells	would	 be	 susceptible	 to	 apoptosis	 owing	 to	
TNFα	secretion	by	senescent	cells.	To	test	this	hypothesis,	we	dis-
abled	 TNFα	 activity	 in	 conditioned	 media	 from	 ERCC1-deficient	
cells	using	a	blocking	antibody,	or	blocked	TNFα	signaling	in	ERCC1-
deficient	cells	using	a	small	molecule	 inhibitor	 (SPD304)	 (He	et	al.,	
2005).	This	small	molecule	inhibitor	interferes	with	protein–protein	
interactions	mediated	by	glycine	122	residues	in	the	trimeric	TNFα 
receptor	type	1	(TNFR1),	thereby	dissociating	the	trimer	and	inhib-
iting	TNFR1	activity.	The	number	of	cleaved	caspase	3-positive	cells	
was	 significantly	 diminished	 by	 treatment	 with	 either	 the	 TNFα-
blocking	antibody	or	SPD304,	as	well	as	an	 inhibitor	of	caspase	8,	
Z-IETD-FMK,	or	a	pan-caspase	inhibitor,	Z-VAD-FMK	(Figure	4d-e).	
These results indicate that apoptosis induced upon ERCC1 deple-
tion	is	mainly	driven	by	a	TNFα-dependent	extrinsic	apoptosis	path-
way	through	TNFR1	and	that	cells	rendered	NER-deficient	cells	by	
ERCC1	depletion	become	susceptible	to	TNFα-dependent	apoptosis	
by cell autonomous and nonautonomous mechanisms.
We	validated	the	increase	in	apoptotic	cells	in vivo using skin from 
Ercc1−/Δ	as	well	as	age-matched	control	mice.	TUNEL-positive	cells	
were	clearly	evident	in	epithelium	and	hair	follicles	of	14-week-old	
Ercc1−/Δ	skin	and	were	even	more	abundant	by	the	age	of	18	weeks,	
whereas	skin	from	age-matched	wt	mice	had	very	 low	numbers	of	
TUNEL-positive	cells	(Figure	5a).	We	attempted	to	perform	TUNEL	
assays	along	with	staining	for	cleaved	caspase	3.	However,	this	ex-
periment	was	technically	challenging.	DNase	 I	 treatment,	a	critical	
step	 for	 the	TUNEL	assay,	generated	a	high	background	signal	 for	
caspase	3	staining,	which	made	interpretation	difficult.
Concomitantly,	expression	of	the	epithelial	stem	cell	marker	(p63),	
basal	stem	cell	marker	(K14),	and	hair	follicle	stem	cell	marker	(Lgr6)	
was significantly decreased in the skin of Ercc1−/Δ mice	(at	4,	14,	and	
18	weeks	of	age)	compared	to	age-matched	wt	mice	(Figure	5b,c).	In	
addition,	 localization	 of	 the	 terminal	 differentiation	marker,	 loricrin,	
was abnormal in the skin of Ercc1−/Δ mice	at	18	weeks	of	age,	indicating	
a	disruption	in	normal	skin	structure,	possibly	due	to	depletion	of	stem	
cell	populations	(Figure	5d).	These	data	indicate	that	ERCC1	deficiency	
in the mouse skin results in cellular senescence followed by apoptosis 
and	suggest	that	stem	cell	depletion,	likely	through	apoptosis,	may	be	
a major cause of the premature skin aging in Ercc1−/Δ mice.
3  | DISCUSSION
Cellular senescence is a cell fate in which cells irreversibly arrest pro-
liferation,	in	part	as	a	defense	mechanism	against	damage	and	neo-
plastic transformation. Emerging evidence indicates that senescent 
cells	accumulate	with	age	in	most,	if	not	all,	mammalian	tissues	and	
organs,	including	the	skin.	Senescent	cells	can	alter	the	tissue	micro-
environment	by	secreting	SASP	factors,	which	can	also	create	a	pro-
inflammatory	milieu.	Consequently,	the	SASP	can	not	only	promote	
F I G U R E  3   Cellular senescence in 
ERCC1-deficient	human	fibroblasts	is	
p53-dependent.	(a)	Quantification	of	SA-
β-gal	staining	is	shown	for	human	HCA2	
fibroblasts in which knockdown of ERCC1 
and/or	p53,	individually	or	in	combination,	
was	performed	using	lentivirus-mediated	
shRNAs.	n	=	3,	mean	±	SEM,	two-tailed	
Welch's	adjusted	t-test.	(b,	c)	RNA	was	
extracted	from	human	fibroblasts	infected	
with	shRNAs	against	ERCC1	and	p53,	and	
analyzed	by	qPCR	for	several	senescence	
and	SASP	markers.	β-actin	was	used	for	
normalization.	n	=	2,	two-tailed	Welch's	
adjusted t-test.	p-value:	*p	<	.05,	**p	<	.01,	
***p < .001
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cancer,	but	also	many	chronic	and	degenerative	pathologies	associ-
ated	with	aging,	ranging	from	neurodegenerative	diseases	to	diabetes	
(Campisi,	2013;	Palmer	et	al.,	2015).	Therefore,	senescent	cells	can	
be	beneficial	or	deleterious,	depending	on	the	context	and	age	of	the	
organism.	Likewise,	apoptosis,	another	protective	mechanism	against	
stress	and	cancer,	is	dysregulated	during	aging,	which	can	contribute	
to	the	deterioration	of	tissue	and	organ	function	(Childs	et	al.,	2014).
Senescent	 cells	 are	 generally	 resistant	 to	 apoptosis,	 often	 due	
to	 increased	expression	of	anti-apoptotic	proteins	belonging	to	the	
BCL	family.	A	new	class	of	small	molecules,	termed	senolytics,	have	
now been developed that target these proteins to selectively alter the 
fate	of	senescent	cells,	causing	them	to	die	by	apoptosis	(Chang	et	al.,	
2016;	Yosef	et	al.,	2016).	Most	senescent	cells	resist	apoptotic	death,	
although senescent endothelial cells have been reported to undergo 
F I G U R E  4  Apoptosis	in	ERCC1-deficient	human	fibroblasts.	(a)	Representative	images	(left	panel)	and	quantification	(right	panel)	of	
immunofluorescence	staining	for	cleaved	caspase	3	were	obtained	using	human	HCA2	fibroblasts	infected	with	shRNAs	against	ERCC1	
or	scrambled	shRNA.	n	=	3,	at	least	5	fields	and	more	than	250	cells	counted	per	condition,	mean	±	SEM,	two-tailed	one	sample	t-test.	(b)	
Representative	images	(left	panel)	and	quantification	(right	panel)	of	SA-β-gal	staining	followed	by	immunofluorescence	staining	for	cleaved	
caspase	3	were	obtained	in	human	HCA2	fibroblasts	infected	with	shRNAs	against	ERCC1	or	scrambled	control.	n	=	2,	at	least	5	fields	and	
more	than	250	cells	counted	per	condition,	mean	±	SEM.	(c)	TNFα	ELISA	was	performed	on	conditioned	media	obtained	from	human	HCA2	
fibroblasts	infected	with	shRNAs	against	ERCC1	or	scrambled	control.	(d–e)	Immunofluorescence	staining	for	cleaved	caspase	3	in	ERCC1-
deficient human fibroblasts treated with 1 μM	of	the	TNFα	small	molecule	inhibitor	SPD304	or	100	ng/ml	of	TNFα	blocking	antibody	(TNFα 
Ab)	(d),	as	well	as	50	μM	caspase	8	inhibitor	Z-IETD-FMK	(IETD)	or	50	μM	caspase	8	inhibitor	Z-VAD-FMK	(VAD)	(e),	together	with	vehicle	
and	rabbit	IgG	controls.	n	=	2	independent	experiments.	At	least	5	fields	and	more	than	200	cells	were	counted	per	condition,	mean	±	SEM,	
two-tailed	Welch's	adjusted	t-test.	p-value:	*p	<	.05,	**p	<	.01,	***p < .001
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F I G U R E  5  Accumulation	of	apoptotic	cells	and	depletion	of	stem	cells	in	the	skin	of	Ercc1−/Δ	mice.	(a)	TUNEL	assays	in	skin	of	Ercc1−/Δ 
and	wt	mice	at	the	indicated	ages	are	shown	(left	panel);	quantification	of	the	percent	TUNEL-positive	cells	was	performed	using	image	J	
software	(right	panel).	n	=	3–4	animals	per	condition,	mean	±	SEM,	two-tailed	one	sample	t-test.	(b)	Representative	images	(left	panel)	of	
immunofluorescence	staining	for	p63	and	K14	were	obtained	in	skin	of	Ercc1−/Δ	and	wt	mice	at	18	weeks	of	age.	Quantification	of	p63	signal	
intensity	(right	panel)	was	performed	on	K14-positive	cells.	n	=	5	animals	per	condition,	at	least	5	fields	and	250	cells	counted	per	condition,	
mean ± SEM,	two-tailed	one	sample	t-test.	(c,	d)	Representative	images	of	immunofluorescence	staining	for	Lgr6	(c),	and	loricrin	together	
with	vimentin	(d),	were	obtained	in	skin	of	Ercc1−/Δ	and	wt	mice	at	18	weeks	of	age.	n	=	3	animals	per	condition,	at	least	5	fields	and	250	cells	
counted	per	condition,	mean	±	SEM,	two-tailed	Welch's	adjusted	t-test.	p-value:	*p	<	.05,	**p < .01
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a	 cell	 fate	 transition	 to	 apoptosis	 by	 reducing	 anti-apoptotic	 pro-
tein	levels	or	increasing	pro-apoptotic	protein	levels	(Li	et	al.,	2005;	
Matsushita	et	al.,	2001;	Zhang	et	al.,	2002).	Indeed,	we	determined	
that	Bcl2	mRNA	 levels	were	 reduced	 in	 ERCC1-depleted	HCA2	 fi-
broblasts	(data	not	shown).	Here,	we	show	that	ERCC1	depletion	in	
human	fibroblasts	induces	cellular	senescence	and	TNFα,	one	of	the	
SASP	factors	secreted	by	senescent	cells,	which	promotes	apoptosis	
in neighboring cells and in senescent cells themselves due to their 
defect	in	DNA	repair	(Figure	S2D).	However,	we	cannot	rule	out	the	
possibility that the results depend on the stage of senescent cells.
ERCC1 depletion in several cell types caused micronuclei forma-
tion,	which	was	 linked	 to	chromosome	mis-segregation	 (Melton	et	
al.,	1998;	Niedernhofer	et	al.,	2004).	Using	DAPI	 staining,	we	also	
observed	micronuclei	 in	ERCC1-deficient	 fibroblasts.	Although	we	
have	not	 tested	 this	 hypothesis	 directly,	 it	 is	 conceivable	 that	 the	
formation	 of	micronuclei	 and	 possibly	 cytosolic	 DNA	 triggers	 the	
cGAS-STING	pathway,	thereby	activating	NF-κB and elevating type 
I	IFN	signaling,	both	of	which	were	recently	shown	to	occur	in	senes-
cent	cells	(De	Cecco	et	al.,	2019).	Indeed,	Tilstra	et	al.	reported	that	
NF-κB activation was significantly enhanced in multiple tissues from 
Ercc1–/Δ	mice,	 including	 kidney,	 liver,	 pancreas,	 spleen	 and	muscle	
(Tilstra	et	al.,	2012).	In	addition,	it	was	reported	that	IFN-γ activates 
the	 transcription	 of	 TNFα	 (Vila-del	 Sol,	 Punzon,	 &	 Fresno,	 2008). 
Thus,	the	DNA	repair	defects	in	Ercc1-deficient	cells	could	possibly	
result	from	activation	of	the	cGAS-STING-type	I	IFN	pathway,	sub-
sequent	NF-κB	activation,	followed	by	TNFα-induced	apoptosis.
ERCC1	 participates	 in	 several,	 related	DNA	 repair	 processes,	 in-
cluding	NER,	TCR	and	interstrand	crosslinking	repair	(Dolle	et	al.,	2011;	
Weeda	et	al.,	1997).	Ercc1−/Δ mice are a model for human Cockayne and 
COF	syndromes,	which	are	rare	progeroid	syndromes	with	extremely	
short	lifespans	(Gregg	et	al.,	2011;	Vermeij,	Dollé,	et	al.,	2016).	Increases	
in both cellular senescence and apoptosis in Ercc1−/Δ mice have been 
reported	(Niedernhofer	et	al.,	2006;	Robinson	et	al.,	2018;	Takayama	et	
al.,	2014;	Tilstra	et	al.,	2012;	Weeda	et	al.,	1997).	These	two	processes	
are	partly	interconnected	by	common	molecular	pathways	(Childs	et	al.,	
2014),	but	how	they	interact	is	not	clear.	Our	surprising	finding	that	both	
processes	 are	 induced,	presumably	 sequentially,	 by	ERCC1	depletion	
identifies a potential mechanism – namely that apoptosis is caused by a 
SASP	factor,	TNFα,	secreted	by	senescent	cells.	Yet,	this	TNFα secretion 
promotes	apoptosis	only	under	the	circumstances	where	DNA	repair	is	
compromised.	Indeed,	although	TNFα can be a strong inducer of apop-
tosis,	it	cannot	trigger	apoptosis	in	normal	cells	that	are	capable	of	rapid	
DNA	damage	 repair	 (Sedger	&	McDermott,	2014).	However,	ERCC1-
depleted	cells	that	are	deficient	in	NER	become	susceptible	to	TNFα-
driven	apoptosis.	It	has	been	shown	that	TNFα increases the proportion 
of	cells	entering	S	phase	and	thus	causes	replication	stress,	which	can	
result	 in	apoptosis	 in	NER-incompetent	premalignant	cells	(Faurschou	
et	 al.,	 2008).	Here,	 it	 is	 also	possible	 that	TNFα	 secreted	by	ERCC1-
depleted	senescent	cells	could	trigger	entry	into	S	phase,	and	thus	in-
duce	apoptosis	 in	DNA	repair-deficient	neighboring	cells.	 In	addition,	
TNFα secretion could induce apoptosis in a cell autonomous manner.
Recent findings show that caloric restriction can be an effective 
therapeutic intervention in Ercc1−/Δ mice by reducing the burden of 
DNA	damage	(Vermeij,	Dollé,	et	al.,	2016).	Restricting	calories	has	also	
been	shown	to	reduce	serum	levels	of	TNFα	(Phillips	&	Leeuwenburgh,	
2005),	suggesting	that	caloric	restriction	might	significantly	reduce	the	
upregulation	of	TNFα in Ercc1−/Δ	mice	(Chen	et	al.,	2013;	Karakasilioti	et	
al.,	2013;	Roh	et	al.,	2013).	This	dampening	could	in	turn	diminish	TNFα-
induced	 apoptosis,	 which	 could	 delay	 the	 accelerated	 aging	 pheno-
types	and	possibly	explain	the	extended	median	and	maximal	lifespans	
observed in calorie restricted Ercc1−/Δ	mice	(Vermeij,	Dollé,	et	al.,	2016).
Anti-TNFα therapy is approved to treat many inflammatory dis-
eases,	 including	rheumatoid	arthritis,	psoriasis	and	Crohn's	disease	
(Sedger	&	McDermott,	 2014).	 Blocking	 TNFα signaling effectively 
prevents	 the	 induction	 of	 inflammation	 mediators	 such	 as	 IL-6	
(Gupta,	2002).	Here,	we	suggest	a	novel	anti-TNFα therapeutic ap-
proach	to	prevent	apoptosis	by	TNFα	signaling.	Anti-TNFα therapy 
could present an alternative intervention in Ercc1−/Δ mice to counter-
act	aging	phenotypes,	such	as	those	in	the	skin,	although	anti-TNFα 
therapy	would	reduce	apoptosis	without	preventing	DNA	damage.
In	 4-week-old	 Ercc1−/Δ	 mice,	 which	 was	 the	 age	 at	 which	 we	
began	eliminating	senescent	cells,	 these	cells	already	accumulated	
and	secreted	TNFα that could trigger apoptosis in neighboring cells. 
We	speculate	that	this	is	why	we	failed	to	rescue	any	aging	pheno-
type	and	could	not	detect	any	effect	on	health	or	lifespan.	However,	
we	cannot	rule	out	the	possibility	that	clearance	of	p16-positive	se-
nescent	 cells	 did	not	 affect	ERCC1	depletion-induced	phenotypes	
because senescence in these animals is primarily driven by p21. By 
14	weeks	of	age,	apoptotic	cells	were	clearly	apparent	and	stem	cell	
pools	were	significantly	depleted.	Therefore,	as	a	more	compelling	
and	long-term	therapy,	we	suggest	a	combination	of	eliminating	se-
nescent cells in a timely fashion and replenishing stem cells might 
reduce	the	DNA	damage	response	(Ocampo	et	al.,	2016),	and	delay	
or rejuvenate the aging phenotypes in Ercc1−/Δ mice.
In	humans,	ERCC1	mutations	at	residues	158	and	231,	yielding	a	
premature	Q158X	termination	mutation,	and	a	F231L	mutation	in	the	
XPF-interacting	domain	have	been	reported	to	cause	Cockayne	and	
COFS	syndromes	 (Gregg	et	al.,	2011;	Jaspers	et	al.,	2007).	Patients	
with	Cockayne	and	COFS	syndromes	develop	postnatal	brain	growth	
failure	and	degeneration	of	multiple	tissues,	resulting	in	cachexia,	de-
mentia	and	premature	aging,	as	well	as	a	shortened	lifespan	(Wilson	
et	 al.,	 2016)	 as	 observed	 in	 Ercc1−/Δ	 mice.	 Unfortunately,	 the	 cur-
rent treatment for those patients is limited to symptomatic support 
(Wilson	et	al.,	2016).	Our	findings	suggest	a	novel	therapeutic	inter-
vention	for	long-term	health	benefits	in	these	patients,	namely	stem	
cell pool replenishment along with the clearance of senescent cells.
4  | E XPERIMENTAL PROCEDURES
4.1 | Cell cultures
HCA2	 (from	 O.	 Pereira-Smith)	 and	 IMR90	 (from	 American	 Type	
Culture	Collection)	human	fibroblasts	were	cultured	in	DMEM	sup-
plemented	with	10%	FBS	(Invitrogen)	and	penicillin/streptomycin	at	
3%	oxygen	and	10%	CO2.
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4.2 | Chemicals and treatments
The	 TNFα-blocking	 antibody	 was	 from	 Cell	 Signaling	 Technology,	
the	small	molecule	TNFα	 inhibitor	(SPD304),	which	interferes	with	
protein–protein interactions mediated by glycine 122 residues in 
the	 trimeric	 TNFα	 receptor	 type	 1	 (TNFR1),	 thereby	 dissociating	
the	 trimer	 and	 inhibiting	 TNFR1	 activity,	was	 from	Sigma-Aldrich,	
and	the	caspase	8	(Z-IETD-FMK)	and	pan-caspase	(Z-VAD-FMK)	in-
hibitors	were	 from	R&D	Systems.	Human	 fibroblasts	were	seeded	
and,	 the	next	day,	 infected	with	pLKO.1-ERCC1	or	 control	 lentivi-
ruses,	followed	by	treatment	every	other	day	with	100	ng/ml	TNFα-
blocking	 antibody,	 1	 μM	 SPD304,	 50	 μM	 Z-IETD-FMK	 or	 50	 μM	
Z-VAD-FMK,	together	with	vehicle	controls.
4.3 | Animals
Animal	 studies	 were	 conducted	 in	 compliance	 with	 protocols	 ap-
proved	by	the	ethics	committee	of	the	National	Institutes	for	Public	
Health	and	the	Environment	(RIVM)	in	the	Netherlands.	Ercc1+/Δ and 
Ercc1+/−	mice	(from	genetically	pure	C57BL6J	and	FVB	backgrounds)	
were crossed to obtain Ercc1−/Δ offspring with a genetically uniform 
F1	C57BL6J/FVB	hybrid	background	 (Dolle	et	al.,	2011;	Weeda	et	
al.,	1997).	Typical	unfavorable	characteristics,	 such	as	blindness	 in	
the	 FVB	background	 or	 deafness	 in	 the	C57BL6J	 background,	 do	
not	occur	in	this	hybrid	background.	Since	Ercc1−/Δ	mice	are	smaller,	
food was administered within the cages and water bottles with long 
nozzles	were	used	from	~2	weeks	of	age.	Animals	were	maintained	
in	a	controlled	environment	(20–22°C;	12	hr	light:12	hr	dark	cycle).	
Wild-type	F1	littermates	at	the	indicated	ages	were	used	as	controls.	
All	animals	were	bred	and	maintained	on	AIN93G	synthetic	pellets	
(Research	Diet	 Services	 B.V.;	 gross	 energy	 content	 4.9	 kcal/g	 dry	
mass,	digestible	energy	3.97	kcal/g).	To	eliminate	senescent	cells	in	
Ercc1−/Δ/p16-3MR	±	mice,	mice	were	intraperitoneally	injected	with	
a	single	daily	dose	of	25	mg	ganciclovir	(GCV)	per	kg	every	4th	week	
for	5	consecutive	days,	starting	from	4-weeks	of	age	(n	=	8	per	gen-
der	and	treatment).	Control	mice	were	treated	with	vehicle	(PBS).
4.4 | Genetic manipulations and gene 
expression analysis
Lentiviral	 vectors	 (pLKO.1-puro)	 encoding	 shRNAs	 against	 ERCC1	
were	purchased	from	Dharmacon.	pLKO.1-ERCC1	lentiviruses	were	
packaged	 in	 HEK293FT	 and	 supernatants	 were	 collected	 after	
48	hr.	Cells	were	infected	with	the	titrated	lentiviruses,	followed	by	
selection in 1 μg/ml	puromycin	for	3	days.	For	siRNA	experiments,	
cells	 were	 transfected	 with	 50	 pmole	 ERCC1	 siRNA	 (Santa	 Cruz	
Biotechnology)	using	Lipofectamine	2000	(Invitrogen)	for	8	hr,	as	per	
the	manufacturer's	recommendation.	Cells	were	collected	for	analy-
sis 7 days after infection or transfection. 1 μg	total	RNA	was	used	to	
prepare	cDNA	using	the	High	Capacity	cDNA	Reverse	Transcription	
Kit	(Life	Technologies),	followed	by	real-time	qPCR	using	the	Roche	
Universal	Probe	Library	system	and	a	Light	Cycler	480	(Roche).	All	
samples	were	analyzed	in	triplicate	using	gene-specific	primers	and	
were	normalized	to	β-actin	(Wiley	et	al.,	2016).
4.5 | SA-β-gal staining and EdU labeling
Cells	 were	 fixed	 and	 processed	 for	 senescence-associated	
β-galactosidase	(SA-β-gal)	staining	as	per	the	manufacturer's	instruc-
tion	(Biovision).	Skin	tissues,	frozen	in	OCT,	were	cut	(7–8	μm sec-
tions)	and	processed	for	SA-β-gal	and	Fast	Red	staining,	as	described	
(Velarde,	Demaria,	Melov,	&	Campisi,	 2015;	Wiley	 et	 al.,	 2016).	A	
Nikon	 Eclipse	 E800	microscope	was	 used	 for	 imaging	 and	 images	
were	quantified	using	Image	J	software.
Cell proliferation was evaluated by incorporation of 
5-ethynyl-2′-deoxyuridine	 (EdU)	 and	 the	 Click-iT	 EdU	 Cell	
Proliferation	Assay	Kit	 (Invitrogen).	Briefly,	cells	were	given	10	μM	
EdU	 for	 24	 hr	 before	 fixation,	 permeabilized	 and	 incubated	 with	
Click-iT	reaction	cocktail	as	per	the	manufacturer's	 instructions.	A	
Zeiss	LSM780	confocal	microscope	was	used	 for	 imaging,	and	 im-
ages	were	quantified	using	 Image	 J	 software.	>100	cells	 from	5–7	
different	 fields	were	quantified	per	condition,	and	all	experiments	
were done in duplicate.
4.6 | Immunofluorescence staining
Human	cells	and	skin	cryosections	 (7–8	μm)	were	fixed	 in	4%	par-
aformaldehyde,	 permeabilized,	 blocked	 and	 immunostained	 as	
described	 (Davalos	 et	 al.,	 2013;	 Freund	 et	 al.,	 2012;	 Rodier	 et	 al.,	
2009).	 Primary	 antibodies	 were	 rabbit	 anti-ERCC1	 (Santa	 Cruz	
#sc-10785),	 rabbit	 anti-γH2AX	 (Novus	 #NB100-79967),	 rabbit	
anti-HMGB1	(Abcam	#ab18256),	goat	anti-LMNB1	(Santa	Cruz	#sc-
6217),	 rabbit	 anti-cleaved	 caspase	 3	 (Cell	 Signaling	 #9664),	 rabbit	
anti-p63	(GeneTex	#GTX102425),	chicken	anti-keratin14	(BioLegend	
#906001),	 rabbit	anti-Lgr6	 (Abcam	#ab126747),	 rabbit	anti-loricrin	
(Covance	#PRB-145P)	and	chicken	anti-vimentin	(Abcam	#ab24525).	
Secondary	antibodies	were	Alexa	Fluor	488	anti-mouse,	Alexa	Fluor	
488	 anti-goat,	 Alexa	 Fluor	 488	 anti-chicken	 and	 Alexa	 Fluor	 597	
anti-rabbit	IgG	from	Molecular	Probe.	A	Zeiss	LSM780	confocal	mi-
croscope	was	used	 for	 imaging,	 and	 images	were	quantified	using	
Image	J	software.	>200	cells	in	5–12	different	fields	were	quantified	
per condition.
4.7 | Immunoblotting
Cells	were	 lysed	 and	 proteins	 separated	 by	 SDS-PAGE	 using	 4%–
12%	Bis-Tris	gels,	followed	by	transfer	to	PVD	membranes,	blocking,	
incubation	with	primary	antibodies	overnight	at	4°C,	incubation	with	
HRP-conjugated	secondary	antibodies	for	1	hr	at	room	temperature,	
and detection using enhanced chemiluminescence. Primary anti-
bodies	were	rabbit	anti-ERCC1	 (Santa	Cruz	#sc-10785)	and	mouse	
     |  11 of 13KIM et al.
anti-β-actin	 (Sigma	 #A2228).	 Secondary	 antibodies	 were	 HRP-
conjugated	goat	anti-rabbit	(Bio-Rad)	and	goat	anti-mouse	(Bio-Rad)	
antibodies.
4.8 | TUNEL assay
Frozen	skin	tissues	were	cut,	fixed	and	processed	for	enzymatic	re-
action	using	the	Dead	End	Fluorometric	TUNEL	System	(Promega)	
as	per	the	manufacturer's	instruction.	A	Zeiss	LSM780	confocal	mi-
croscope was used for imaging and the images were quantified using 
Image	J	software.	At	least	three	different	fields	with	>300	cells	per	
field	were	quantified	per	condition,	and	tissues	from	three	different	
animals were used for the assay.
4.9 | TNFα ELISA
Cells	 were	 infected	 with	 lentivirus	 expressing	 ERCC1	 shRNA	 as	
well	 as	 a	 scrambled	 shRNA,	 and	 cultured	 for	 7	 days.	Conditioned	
media	were	collected	 from	cells	cultured	 in	0.2%	serum	for	24	hr,	
followed	 by	 concentration	 using	 Amicon	 Ultra	 Centrifugal	 Filter	
units	(Millipore).	The	concentrated	conditioned	media	were	used	to	
measure	TNFα	concentrations	as	per	the	manufacturer's	instruction	
(TNFα	ELISA	kit	 from	R&D	Systems).	Cell	number	was	determined	
and	used	for	normalization.
4.10 | Statistics
All	data	with	error	bars	are	presented	as	mean	±	SEM,	and	the	indi-
vidual	data	points	(dots)	are	presented	in	the	bar	graphs	(Figures	1a,	
2b,c,	2e-h,	3a,	4a-e,	5a,b,	and	Figure	S2C).	We	used	Welch's	adjusted	
t-test	 (also	called	unequal	variances	 t-test),	a	modified	Student's	 t-
test	under	the	assumption	of	unequal	variances.	Most	of	cell	culture	
experiments	were	done	 in	 triplicate	and	reproduced	at	 least	 three	
times independently.
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